Bio-Rad Laboratories, Inc. (BIO)
Makes lab equipment and diagnostic tests for researchers and hospitals.
$316.41+0.01%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago+14.4%
The outlook
Bio-Rad is trading near the upper end of its 52-week range and above both its 50- and 200-day moving averages, showing upward momentum in its recent trend. Analyst consensus sits at Hold, with the average price target sitting about 6% below the current price, suggesting limited near-term appreciation. The stock carries a elevated trailing P/E of 52.6x.
What’s behind the score
Analyst consensusHold — 2.8 avg of 5 analysts
Price trendAbove its 50- & 200-day averages
52-week range75% of the way from its 52-week low to high
Price targetAvg target -6% vs current price
Analyst price target
~12-month · 5 analysts$297.00average target-6.1% vs now
Now $316.41
Low $275.00High $320.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$8.47B
52-wk high
$343.12
52-wk low
$236.73
50-day avg
$294.13
200-day avg
$295.16
Trailing P/E
52.6